The −675 4G/5G PAI-1 polymorphism confers genetic susceptibility to systemic lupus erythematosus, its clinical manifestations, and comorbidities in Mexican-Mestizo population

• Egile Nagusiak: B. U. Anaya-Macias (Egilea), U. De la Cruz-Mosso (Egilea), C. A. Palafox-Sánchez (Egilea), I. Parra-Rojas (Egilea), G. Martínez-Bonilla (Egilea), L. González-López (Egilea), J. I. Gámez-Nava (Egilea), E. E. Pérez-Guerrero (Egilea), S. L. Barrientos-Avalos (Egilea), J. F. Muñoz-Valle (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2020-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Systemic lupus erythematosus (SLE) involves a broad range of factors that contribute to the development of the disease and its comorbidities. Genetic predisposition influences the development of SLE, and the −675 4G/5G PAI-1 polymorphism has been associated with several pathologies with a chronic in...